NIHR Maudsley BRC Blog

Our latest news and events

Researchers identify genetic blueprint of mania in bipolar disorder

Researchers at King’s College London and the University of Florence have, for the first time, identified the specific genetic blueprint of mania, the defining feature of bipolar disorder.

 

By NIHR Maudsley BRC at 28 Jan 2026
Read more >

NIHR Maudsley BRC: 2025 Year in Review

In 2025, NIHR Maudsley BRC delivered research with real-world impact from evaluating new treatments for depression and migraine to developing innovative approaches to monitoring opioid overdose and diagnosing eating disorders.

By NIHR Maudsley BRC at 19 Dec 2025
Read more >

Who benefits from antidepressants? Using medication switching as a measure of non-response

Switching from one selective serotonin reuptake inhibitor (SSRI) to another antidepressant could be used to measure antidepressant non-response, according to new research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London.

 

By NIHR Maudsley BRC at 28 May 2025
Read more >

Three quarters of people who have taken antidepressants say they were helpful

75% of a sample of nearly 20,000 people who have taken selective serotonin reuptake inhibitors (SSRIs) report they found them helpful, finds new research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London.

By NIHR Maudsley BRC at 13 Mar 2025
Read more >

Global study pinpoints genes for depression across ethnicities

Researchers at King's College London and University of Edinburgh have identified new genetic risk factors for depression across all major global populations for the first time, allowing scientists to predict risk of depression regardless of ethnicity.

 

By NIHR Maudsley BRC at 14 Jan 2025
Read more >